KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Enterprise Value (2017 - 2025)

Guardant Health's Enterprise Value history spans 9 years, with the latest figure at -$1.2 billion for Q4 2025.

  • For Q4 2025, Enterprise Value fell 43.05% year-over-year to -$1.2 billion; the TTM value through Dec 2025 reached -$1.2 billion, down 43.05%, while the annual FY2025 figure was -$1.2 billion, 43.05% down from the prior year.
  • Enterprise Value for Q4 2025 was -$1.2 billion at Guardant Health, down from -$580.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$580.0 million in Q3 2025 and bottomed at -$1.9 billion in Q1 2021.
  • The 5-year median for Enterprise Value is -$960.2 million (2022), against an average of -$1.1 billion.
  • The largest annual shift saw Enterprise Value tumbled 296.35% in 2021 before it surged 50.72% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$932.7 million in 2021, then decreased by 8.41% to -$1.0 billion in 2022, then decreased by 15.57% to -$1.2 billion in 2023, then rose by 28.12% to -$840.0 million in 2024, then crashed by 43.05% to -$1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for GH's Enterprise Value are -$1.2 billion (Q4 2025), -$580.0 million (Q3 2025), and -$629.1 million (Q2 2025).